Completed NA INTERVENTIONAL 4-arm NCT05170113

Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health

A Pilot, Randomized, Double-blind, Placebo-controlled, Parallel Design Study to Evaluate the Effectiveness and Safety of an Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health Among Overall Healthy Participants

Sponsor: Supplement Formulators, Inc.

Conditions Fatigue

Interventions Alpinia galanga formulation Caffeine formulation Placebo Theacrine formulation

Updated 4 times since 2022 Last updated: Jul 25, 2022 Started: Nov 2, 2021 Primary completion: May 31, 2022 Completion: May 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Fatigue and is currently completed. Supplement Formulators, Inc. leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2022 — Sep 2022 [monthly]

Recruiting NA

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Supplement Formulators, Inc.

Data source: Supplement Formulators, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Lauderdale, United States